All (3)News (3)Transcripts (0)Press Releases (0)

News14 days ago

Vor Bio's $100M Public Offering Causes Stock Decline

Vor Bio shares are trading lower after announcing a public offering of 10,000,000 shares at $10.00 each.

News151 days ago

Vor Bio Sees Stock Rise on Major Financing and Licensing Deals

Vor Bio shares are trading higher after announcing a $175 million private placement and an exclusive global license agreement with RemeGen for a late-stage autoimmune asset.

News201 days ago

Vor Bio Shares Drop Amid Strategic Alternatives Exploration

Vor Bio shares are trading lower after the company announced it is exploring strategic alternatives, including potential sales or mergers, and implementing a 95% workforce reduction amid a challenging fundraising environment.